Improving Outcomes in Patients With Kidney Disease Due to Diabetes

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

December 31, 2006

Conditions

DiabetesKidney DiseaseHypertension

Interventions

DRUG

losartan 100 mg orally once daily

DRUG

spironolactone 25 mg orally once daily

DRUG

placebo once orally once daily

Trial Locations (1)

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00381134 - Improving Outcomes in Patients With Kidney Disease Due to Diabetes | Biotech Hunter | Biotech Hunter